Dexcel, OMNII enter into Xantia™ agreement

March 31, 2004
OMNII recently assumed responsibility for all sales, marketing, and distribution functions for Xantia 25% Carbamide Peroxide Brush-On Tooth Whitener.

Dexcel® Pharma and OMNII Oral Pharmaceuticals™ have entered into a marketing and distribution agreement for Xantia™ Brush-On Tooth Whitener.

OMNII recently assumed responsibility for all sales, marketing, and distribution functions for Xantia 25% Carbamide Peroxide Brush-On Tooth Whitener. Xantia 25% Carbamide Peroxide Brush-On tooth whitener is available to consumers only through dental offices.

"Some consumers are looking to brush-on tooth whiteners as an alternative to tray-based whitening systems," said Kevin Thomas, OMNII's chief executive officer. "We believe that by offering a professional strength brush-on whitener that is only available from dental professionals, we are best serving the needs of our customers and their patients."

"Our white & brite® tray-based tooth whitening system was the first professionally-dispensed tooth whitening system available in the United States. Xantia Brush-On Tooth Whitener will give dental professionals a reliable, high-strength option to offer patients who are considering an over-the-counter product, while still being able to monitor their oral health," added Steve Pardue, product manager at OMNII.

"We are pleased to be working with OMNII regarding both Xantia and PerioChip® (chlorhexidine gluconate 2.5 mg.)," said Dodi Gordon, Dexcel Pharma international dental product manager. "Their commitment to providing quality products to the dental market has long been established. Xantia and PerioChip are a natural fit into their existing product line and offer dental professionals additional options to enhance the lives of their patients."